Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Shanghai Pharmaceuticals Holding Co Ltd    601607   CNE000000C82

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Shanghai Pharmaceuticals : to Buy Cardinal Health's Unit for US$557 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/15/2017 | 02:16am CET
   By Joanne Chiu 
 

Shanghai Pharmaceuticals Holding Co. (2607.HK) plans to buy the pharmaceutical distribution network of U.S. company Cardinal Health Inc. in Hong Kong and mainland China for US$557 million.

The Hong Kong listed pharmaceutical company said Wednesday that it has agreed to buy the entire interest in Cardinal Health's unit -Cardinal Health (L) Co. in a bid to broaden the coverage of its distribution network in China and build up direct-to-pharmacy chain with specialty brands.

Cardinal Health (L) Co. operates 14 direct sales companies and 17 distribution and operation centres in China with a total storage area of around 146,000 square meters and around 7,000 square meters cold storage capacity, it said.

Write to Joanne Chiu at [email protected]

Valeurs citées dans l'article
ChangeLast1st jan.
CARDINAL HEALTH -0.64% 68.37 Delayed Quote.12.36%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHANGHAI PHARMACEUTICALS H
02/02SHANGHAI PHARMACEUTICALS : ·completion the entire equity interest in cardinal ma..
PU
02/01SHANGHAI PHARMACEUTICALS : ·Monthly Return of Equity Issuer on Movements in Secu..
PU
01/26SHANGHAI PHARMACEUTICALS : ·completion of placing of h shares
PU
01/26SHANGHAI PHARMACEUTICALS : ·Next Day Disclosure Return
PU
01/19SHANGHAI PHARMACEUTICALS : SH Pharma to raise HK$3.12bn from shares placing
AQ
01/19SHANGHAI PHARMACEUTICALS : ·placing of new h shares under general mandate
PU
01/11SHANGHAI PHARMACEUTICALS : ·progress on the acquisition of the entire equity int..
PU
2017SHANGHAI PHARMACEUTICALS : HSBC ups Shanghai Pharma to HK$28.7
AQ
2017SHANGHAI PHARMACEUTICALS : Citi lowers Shanghai Pharma to HK$25.5
AQ
2017SHANGHAI PHARMACEUTICALS : buys out Cardinal Health in China to become top distr..
AQ
More news
News from SeekingAlpha
2017Cardinal Health sells China business for $1.2B 
2017WEEK IN REVIEW : Vivace Details Its Capital Efficient Plan To Develop Novel Canc.. 
2015WEEK IN REVIEW : Hepalink Pharma Buys U.S.-Based CMO Cytovance 
2015WEEK IN REVIEW : Porton Fine Chemicals Buys Dongbang Pharma 
Financials ( CNY)
Sales 2017 134 B
EBIT 2017 4 956 M
Net income 2017 3 536 M
Debt 2017 1 809 M
Yield 2017 1,66%
P/E ratio 2017 16,57
P/E ratio 2018 14,59
EV / Sales 2017 0,44x
EV / Sales 2018 0,40x
Capitalization 56 722 M
Chart SHANGHAI PHARMACEUTICALS H
Duration : Period :
Shanghai Pharmaceuticals H Technical Analysis Chart | 601607 | CNE000000C82 | 4-Traders
Technical analysis trends SHANGHAI PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 25,3  CNY
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Min Zuo President & Executive Director
Jun Zhou Chairman
You Li Xu Chairman-Supervisory Board
Bo Shen Chief Financial Officer, Director & Vice President
Xin Chen Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-9.59%8 929
SINOPHARM HOLDING CO LTD-1.64%11 672
TSURUHA HOLDINGS INC.0.65%7 057
SUNDRUG CO LTD-7.47%6 115
COSMOS PHARMACEUTICAL CORP-15.77%3 687
SUGI HOLDINGS CO.,LTD.0.69%3 428